Skip to content

AnPoMed

Active Risk: not assessed Private limited companyfounded 2025active for less than a yearBlarenhoek 4, 9620 ZottegemKBO/BCE: BE 1032.161.162
AnPoMed
Follow ReportCompare

Board

1 director, no change since January 2026
POELMAN Anouck Gerda Paul
Director (not named in the articles)
appointed by deed of 29-12-2025 term without a fixed end

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
POELMAN Anouck Gerda Paul
Director (not named in the articles)
STEVENS Michiel
Director (not named in the articles)
BoardEarlier
Mandates as a list
  • POELMAN Anouck Gerda Paul
    • Director (not named in the articles), appointed by deed of 29-12-2025, still in office
  • STEVENS Michiel
    • Director (not named in the articles), appointed by deed of 29-12-2025, until 30-01-2026

Control

Founder
POELMAN Anouck Gerda Paul
This company
AnPoMed

Capital

Contribution
€3,000
Shares
100
Contribution per share
€30
Source
deed of 29-12-2025

Articles of association

deed of 29-12-2025 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“Plaats, dag en uur van de jaarvergadering van de aandeelhouders (artikel 10) Een gewone algemene vergadering van aandeelhouders vindt elk…”

Shareholders

At incorporation deed of 29-12-2025 ↗

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure